Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.

Bastard P. et al, (2022), J Exp Med, 219

Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study

YAO P. et al, (2022), BMJ Open

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Närhi F. et al, (2022), The Lancet Digital Health, 4, e220 - e234

Vitamin D Deficiency and Its Association with Iron Deficiency in African Children.

Mogire RM. et al, (2022), Nutrients, 14

Identification of host-pathogen-disease relationships using a scalable Multiplex Serology platform in UK Biobank

MENTZER A. et al, (2022), Nature Communications

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Tomic A. et al, (2022), Nat Commun, 13

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.

Otter AD. et al, (2022), Microbiol Spectr, 10

Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control

Dong T. et al, (2022)

Response to Letter to the Editor by Ish et al. entitled 'COVID-19 vaccine equity-the need of the hour'.

Maclean P. et al, (2022), QJM

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.

Dejnirattisai W. et al, (2022), Cell

Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Keeling MJ. et al, (2022), Statistical Methods in Medical Research

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

Angyal A. et al, (2022), The Lancet Microbe, 3, e21 - e31

Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.

Dejnirattisai W. et al, (2021)

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

LANDRAY M. et al, (2021), The Lancet

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial.

Fisher BA. et al, (2021), Lancet Respir Med

Why do breakthrough COVID-19 infections occur in the vaccinated?

Maclean P. et al, (2021), QJM

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.

Peng Y. et al, (2021), Nat Immunol

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.

Liu C. et al, (2021), Cell Host Microbe

Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.

Mentzer DAJ. et al, (2021), J Infect

Load More

Include forthcoming?